Home
Inovio Biomedical Provides Updated Interim Data on Phase I/II Clinical Study of... Print E-mail
Thursday, 05 June 2008
SAN DIEGO----Inovio Biomedical Corporation , a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that Dr. Christian H. Ottensmeier, MD, PhD, Cancer Research UK Senior Clinical Research Fellow at the University of Southampton, presented updated interim data from a clinical study of an experimental DNA-based prostate cancer vaccine at the ...
Read more
Related news items:

 
< Prev   Next >